Clinical trial Recruiting at 2 sites Interventional Ages 18 to 70

CRP tests and patient leaflets to reduce antibiotics for adults with respiratory infections in Kyrgyzstan

Official title: CRP and Patient Information Leaflets to Optimise Antibiotic Treatments for Adults With Respiratory Tract Infections in Primary Care in Kyrgyzstan

Run by Copenhagen University Hospital, Rigshospitalet · NCT07261969 · Data updated 2026-11-12

This project will test whether using quick CRP blood tests and easy-to-read patient information leaflets helps doctors in Kyrgyzstan prescribe fewer antibiotics for adults with recent respiratory symptoms.

More Inflammation Biomarkers trials

Quick facts

Study typeInterventional
Ages18 Years to 70 Years
SexAll
Enrollment1050 (estimated)
SponsorCopenhagen University Hospital, Rigshospitalet
Academic / other
Locations2 sites (Sokuluk Village, Chui Region and 1 other locations)
StatusRecruiting
StartedDecember 18, 2024
Main results expectedMarch 30, 2026
Study endsApril 30, 2027
Registry record updatedDecember 3, 2025
Trial IDNCT07261969 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–70 presenting to participating primary care centers with acute respiratory symptoms of less than two weeks who can give informed consent and complete follow-up are ideal candidates.

Probably not a fit

Patients who are severely ill or need urgent referral, are immunosuppressed, pregnant, recently on antibiotics, or cannot complete follow-up are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicentre, open-label randomized trial will enroll adults (18–70) with acute respiratory symptoms at 14 rural and one urban primary care centres in Kyrgyzstan. Participants are randomized in a 2x3 design: patient information leaflet versus no leaflet, and one of three CRP point-of-care test thresholds (20, 40, or 60 mg/L), creating six groups. Clinicians will use CRP results and the leaflet allocation to guide antibiotic prescribing, with 21 days of blinded follow-up to monitor antibiotic use, clinical recovery, and safety. Primary outcomes include antibiotic prescribing and patient safety, and secondary outcomes include reconsultations and symptom duration.

Why it matters

Potential benefit: If successful, the approach could safely reduce unnecessary antibiotic prescriptions and help curb antimicrobial resistance in Kyrgyz primary care.

How similar studies have gone: Previous work, including the COORDINATE trial, showed CRP point-of-care testing can reduce antibiotic use without compromising safety, but the best CRP cut-offs for adults remain unproven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 to 70 years with ARTI according to the attending HCW;
* Having at least one of the following respiratory symptoms lasting for less than 2 weeks (with or without a fever):

  * cough;
  * shortness of breath;
  * sore throat;
  * stuffy nose;
  * wheezing.
* Able and willing to comply with all study requirements.
* Able and willing to give informed consent.

Exclusion Criteria:

* Severely ill and in need of urgent referral where measurement of POCT CRP is not relevant or would delay the process;
* Terminally ill patients;
* Patients with known immunosuppression or severe chronic disease (HIV, liver failure, kidney failure, history of neoplastic disease, long term systemic steroid use or similar conditions as assessed by the health worker or research team);
* Patients who are not able to participate in follow-up procedures (lack of telephone etc.);
* Have taken antibiotics within 24 hours before the index consultation;
* Pregnant women;
* Unable or unwilling to provide informed consent.

Where it's running

  • Sokuluk Family Medicine Center
    Sokuluk Village, Chui Region, Kyrgyzstan
    Recruiting
  • Azim Azhybek uulu
    At-Bashy Village, Naryn Region, Kyrgyzstan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.